eMI Aesthetics vs Vaylen
Two GLP-1 desks, one scoreboard. We put eMI Aesthetics and Vaylen head-to-head on the published Brief Score — the same six factors, scored the same way.
eMI Aesthetics
Vaylen
The verdict
Vaylen takes this head-to-head.
Vaylen scores 87 to 71 on our six-factor Brief Score — A full-service, LegitScript-certified desk pairing brand access and an oral route with nationwide reach at a fair mid price.
That doesn't make eMI Aesthetics a bad call — it's best for shoppers wanting compounded sema or tirz in all 50 states with an ai progress simulator. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| eMI Aesthetics | Vaylen | |
|---|---|---|
| Brief Score | 71/100 (C) | 87/100 (B+) |
| Semaglutide | From $179/mo (all doses, compounded) | $179/mo |
| Tirzepatide | Not disclosed | $239/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
| On the tracker | Newnew to the tracker, no prior reading | Stableprice stable |
eMI Aesthetics: New to the tracker on 1 August 2026. The published line reads From $179/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.
Vaylen: $179 sema / $239 tirz; brand + oral + LegitScript across all 50 states.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.